- €525.90m
- €472.90m
- €954.62m
- 90
- 63
- 81
- 94
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 592 | 690 | 680 | 896 | 955 |
Cost of Revenue | |||||
Gross Profit | 244 | 318 | 310 | 355 | 367 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 538 | 660 | 661 | 852 | 921 |
Operating Profit | 54.4 | 30 | 19 | 44.6 | 33.9 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 44.3 | 23.4 | 13 | 42.9 | 34.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 34.6 | 10.7 | 1.05 | 24.2 | 24.3 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 26.9 | 12.7 | -11.6 | 11.8 | 12.1 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 26.9 | 12.7 | -11.6 | 11.8 | 12.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.72 | 2.42 | 0.594 | 2.36 | 2.36 |
Dividends per Share | |||||
Special Dividends per Share |